PATENT CLAIM ANALYSIS

Application Number: 15574769
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-05
Patent Classification: ["514", "339000"]

Abstract:
Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.

Claim (Index 21):
The method of any one of  claims 16 - 20 , wherein the pruritus is associated with dermatitis herpetiformis, dermatomyositis, pemphigoid, Sjogren's syndrome, Darier's disease, Hailey-Hailey disease, Ichthyoses, Sjogren-Larsson syndrome, dermatophytosis, folliculitis, impetigo and other bacterial infections, insect bites, pediculosis, ccabies, viral infection, asteatosis, atopic eczema, contact dermatitis, drug reaction, lichen planus, lichen simplex chronicus, mastocytosis (urticaria pigmentosa), miliaria, psoriasis, scar(s), urticaria, cutaneous T-cell lymphoma or mycosis fungoides, cutaneous B-cell lymphoma, leukemia cutis, pemphigoid gestationis, polymorphic eruption of pregnancy or prurigo gestationis.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14628970', '13439495', '15539088', '15060398', '15022180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884090875633292
- 35 USC 102 Novelty (BERT): 0.514739010472281
- Combined Prediction Score: 0.7610420798542243
- Mean Citation Score: 276.17016
- Max Citation Score: 305.50748
- Similarity Product: 237.9212528539801

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test